ArticleInternational journal of colorectal disease2022

Comparison of safety and efficacy of fluorouracil + oxaliplatin + irinotecan (FOLFOXIRI) and modified FOLFOXIRI with bevacizumab for metastatic colorectal cancer: data from clinical practice.

Keisuke Kazama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.